Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Antimicrob Agents Chemother
2006 Oct 01;5010:3305-11. doi: 10.1128/AAC.00490-06.
Show Gene links
Show Anatomy links
Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH.
Mason AJ
,
Gasnier C
,
Kichler A
,
Prévost G
,
Aunis D
,
Metz-Boutigue MH
,
Bechinger B
.
???displayArticle.abstract???
The histidine-rich amphipathic cationic peptide LAH4 has antibiotic and DNA delivery capabilities. Here, we explore the interaction of peptides from this family with model membranes as monitored by solid-state (2)H nuclear magnetic resonance and their antibiotic activities against a range of bacteria. At neutral pH, the membrane disruption is weak, but at acidic pH, the peptides strongly disturb the anionic lipid component of bacterial membranes and cause bacterial lysis. The peptides are effective antibiotics at both pH 7.2 and pH 5.5, although the antibacterial activity is strongly affected by the change in pH. At neutral pH, the LAH peptides were active against both methicillin-resistant and -sensitive Staphylococcus aureus strains but ineffective against Pseudomonas aeruginosa. In contrast, the LAH peptides were highly active against P. aeruginosa in an acidic environment, as is found in the epithelial-lining fluid of cystic fibrosis patients. Our results show that modest antibiotic activity of histidine-rich peptides can be dramatically enhanced by inducing membrane disruption, in this case by lowering the pH, and that histidine-rich peptides have potential as future antibiotic agents.
Aisenbrey,
Interactions involved in the realignment of membrane-associated helices. An investigation using oriented solid-state NMR and attenuated total reflection Fourier transform infrared spectroscopies.
2006, Pubmed
Aisenbrey,
Interactions involved in the realignment of membrane-associated helices. An investigation using oriented solid-state NMR and attenuated total reflection Fourier transform infrared spectroscopies.
2006,
Pubmed
Bal,
Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.
2005,
Pubmed
Barry,
Direct NMR evidence for ethanol binding to the lipid-water interface of phospholipid bilayers.
1994,
Pubmed
Bechinger,
The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy.
1999,
Pubmed
,
Xenbase
Bechinger,
Detergent-like properties of magainin antibiotic peptides: a 31P solid-state NMR spectroscopy study.
2005,
Pubmed
Bechinger,
Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy.
1993,
Pubmed
,
Xenbase
Bechinger,
Towards membrane protein design: pH-sensitive topology of histidine-containing polypeptides.
1996,
Pubmed
Bechinger,
Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin.
1997,
Pubmed
,
Xenbase
Boman,
Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine.
1993,
Pubmed
Brogden,
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
2005,
Pubmed
Cruciani,
Magainin 2, a natural antibiotic from frog skin, forms ion channels in lipid bilayer membranes.
1992,
Pubmed
,
Xenbase
Davis,
The description of membrane lipid conformation, order and dynamics by 2H-NMR.
1983,
Pubmed
Duclohier,
Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayers.
1989,
Pubmed
,
Xenbase
Friedrich,
Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria.
2000,
Pubmed
Hancock,
Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics.
2002,
Pubmed
Kichler,
Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells.
2003,
Pubmed
Kichler,
Cationic amphipathic histidine-rich peptides for gene delivery.
2006,
Pubmed
Maciá,
Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.
2005,
Pubmed
Mason,
A spectroscopic study of the membrane interaction of tuberoinfundibular peptide of 39 residues (TIP39).
2005,
Pubmed
Mason,
The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes.
2006,
Pubmed
Mason,
A spectroscopic study of the membrane interaction of the antimicrobial peptide Pleurocidin.
2006,
Pubmed
Oliver,
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.
2000,
Pubmed
Park,
Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions.
1998,
Pubmed
,
Xenbase
Patrzykat,
Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli.
2002,
Pubmed
Ramamoorthy,
Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin.
2006,
Pubmed
,
Xenbase
Seelig,
The dynamic structure of fatty acyl chains in a phospholipid bilayer measured by deuterium magnetic resonance.
1974,
Pubmed
Subbalakshmi,
Mechanism of antimicrobial action of indolicidin.
1998,
Pubmed
Tate,
Airways in cystic fibrosis are acidified: detection by exhaled breath condensate.
2002,
Pubmed
Vogt,
The interactions of histidine-containing amphipathic helical peptide antibiotics with lipid bilayers. The effects of charges and pH.
1999,
Pubmed
Wu,
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.
1999,
Pubmed
Yonezawa,
Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action.
1992,
Pubmed
Zasloff,
Antimicrobial peptides of multicellular organisms.
2002,
Pubmed
Zasloff,
Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.
1987,
Pubmed
,
Xenbase
Zasloff,
Antimicrobial activity of synthetic magainin peptides and several analogues.
1988,
Pubmed
,
Xenbase
Zhang,
Antimicrobial peptide therapeutics for cystic fibrosis.
2005,
Pubmed
